Background: The peroxisome proliferator-activated receptor γ (PPARγ) is a ligand-dependent transcription factor involved in many aspects of metabolism, immune response and development. Numerous studies relying on tissue-specific invalidation of the Pparg gene have shown distinct facets of its activity, whereas the effects of its systemic inactivation remain unexplored due to embryonic lethality. By maintaining PPARγ expression in the placenta, we recently generated a mouse model carrying Pparg full body deletion (Pparg
Introduction
Adipose tissue is a plastic tissue central to metabolic health by virtue of both its fat-storage and endocrine roles; the extreme deviations of its mass are associated with severe pathological states. Obesity is a risk factor for metabolic syndrome associated with hyperglycemia, hypertension, hyperlipidemia, insulin resistance, and with increased risk for cardiovascular diseases and type-2 diabetes [1, 2] . It is accompanied by pronounced alterations in the secretory profile of adipocytes and macrophages, resulting in chronic low-grade inflammation and subsequent adipocyte dysfunction [3] [4] [5] . Opposite to obesity, the lack of fat is called lipoatrophy. The most severe human form is the Berardinelli-Seip syndrome, which is a congenital generalized lipodystrophy provoked by mutations in BSCL2 or in AGPAT2 genes. Interestingly, lipodystrophic patients suffer from the same disorders as obese patients, including severe insulin resistance and type-2 diabetes [6, 7] . A unifying model proposes that when adipose tissue expandability is exhausted, such as in the presence of excess of lipids (obesity) or of insufficient body fat capacity (lipodistrophy), lipids cannot be safely stored in ectopic fat and accumulate in ectopic tissues, promoting lipotoxicity, insulin resistance and apoptosis [8] [9] [10] .
Adipose tissue development relies on the activity of the adipogenesis master regulator peroxisome proliferator-activated receptor γ (PPARγ), a ligand-dependent transcription factor belonging to the nuclear receptor superfamily [11, 12] . PPARγ has many other metabolic activities including insulin sensitization. Indeed, synthetic PPARγ ligands such as thiazolidinediones (TZDs) have proven to be potent in the treatment of type-2 diabetes [13, 14] . Conversely, rare natural heterozygous mutations in humans affecting PPARγ binding or activity lead to the development of partial lipodystrophy, insulinoresistance, hepatic steatosis and hypertriglyceridemia [7, 15] . Moreover, deletion of the PPARγ2 isoform in the obese ob/ob background [16] as well as the fat-specific PPARγ deletion in Adipoq-Cre/Pparg fl/fl mice (PPARγFKO mice) [17] , invariably led to insulin resistance, hyperglycemia and hyperlipidemia, although resulting in different degrees of adipose tissue reduction. Likewise, the deletion of PPARγ in muscle confirmed its essential role to maintain whole body insulin sensitivity [18] . Finally, macrophage-specific deletion of PPARγ predisposed mice to diet-induced insulin resistance [19] . The effect of PPARγ whole body deletion could however not be explored due to placental defects [20, 21] . In a first attempt to circumvent this embryonic lethality by preserving PPARγ expression in the placenta, Meox-Cre mice were bred with PPARγ-floxed mice [22] . However, this approach gave rise to high mosaicism with various degree of Cre-dependent recombination depending on tissues (our unpublished results and [23] ).
By using Sox2-Cre mediated recombination instead to delete PPARγ in the embryo while maintaining its expression in the placenta [23] , we obtained viable whole-body PPARγ null pups [21] . Whereas PPARγ null mice show post-natal lethality and delayed growth during the suckling period, they recover and grow properly after weaning. Importantly, throughout their life, PPARγ null mice exhibit a total lack of white and brown adipose tissue. In the present report, we analyzed the severe metabolic disorders that accompany this total lipoatrophy.
Materials and methods

Animals
Animal care and treatments were performed in agreement with the guidelines established by the European Community Council Directives (86/609/EEC) and were approved by the commission for animal experimentation of the cantonal veterinary services (Canton of Vaud). Whole body Pparg null mice were obtained as previously described [24] . Mice were kept in a 12:12 h light:dark cycle and fed a standard chow diet (cat. 3436, Kliba Nafag, Kaiseraugst, Switzerland) with water ad libitum. For growth curves Pparg Δ/Δ and littermate control males and females (N = 5-10) were distributed among cages as random blocks of 1 Pparg null and 2 control mice. Random blocking was also used in all experiments.
Mouse embryonic fibroblasts
MEFs were isolated from E13.5 embryos. Briefly, after removal of head and internal organs, embryos were minced and incubated for 20 min at 37°C in 0.25% Trypsin-EDTA. Cell suspensions were centrifuged, suspended with cell culture media (DMEM/F-12 supplemented with 10% FBS, 20 mM glutamine, and penicillin/streptomycin), plated in P100, and cultured at 37°C and 5% CO2. Cells were differentiated in vitro as previously reported [25] , with or without rosiglitazone (0.5 μM). Differentiated MEFs were fixed in 4% paraformaldehyde and stained with 0.3% Oil-Red-O (Sigma) for 10 min.
Clinical parameters
Resistin and leptin were measured using the Luminex technology (Bioplex, Bio-Rad). Plasma and urine biochemical parameters were evaluated on a Cobas C111 analyzer (Roche Diagnostics, Rotkreuz, Switzerland) at the Mouse Metabolic Evaluation Facility of the University of Lausanne. Insulin levels were measured with the Mercodia Ultrasensitive insulin ELISA (Mercodia AB, Sweden).
Body composition
Analyses were performed in duplicate for each mouse with the EchoMRI™ qNMR system (Echo Medical Systems, Houston, TX, USA) under isoflurane anesthesia at the Mouse Metabolic Evaluation Facility (MEF) of the University of Lausanne.
Body temperature
The temperature was measured in 12 weeks old females (N = 6) using a rectal probe (Bioseb) after 4 days of acclimation.
Glucose metabolism
GTT was performed in 10-12 weeks old male and female control and Pparg Δ/Δ mice (N = 8). After 16 h of fasting, glucose (2 g/kg) was injected intraperitoneally. Blood was collected from the tail vein at 0, 15, 30, 60 and 120 min after the injection and glycemia was evaluated by the use of a glucometer (Bayer Breeze 2, Canada). For the ITT, 12 weeks old male and female mice (N = 3-6 per group) were fasted 6 h and then injected intraperitoneally with insulin (0.6 U/Kg). Blood glucose was measured at 0, 15, 30 and 60 min after insulin injection.
Indirect calorimetry
Indirect calorimetry was performed in 12 weeks old mice placed in individual chambers in a 12 cages CLAMS system (Columbus Instruments, OH, USA), placed in a temperature-controlled chamber. For ad libitum measurements, CO 2 production, locomotor activity, food and water intake were recorded during 2 cycles of 24-h, with unrestricted food access (N = 6). For the response to feeding-fasting-refeeding transitions, indirect calorimetry measurements included a full day in the ad libitum condition, followed by an overnight (16 h) fasting and a diurnal refeeding period (N = 3; results replicated in 6 independent cohorts of both males and females). For thermoneutrality experiments, calorimetry measurements were recorded during three consecutive intervals of 24 h: a first cohort (N = 3) was put at ambient temperature at 23°C, then 32°C, then 33°C; a second independent cohort (N = 3) was put at ambient temperature at 23°C, then 32°C, then 30°C. Fermentation artifacts were prevented by trapping urine into diaper strips placed underneath the chamber floors. Moreover, during thermoneutrality experiments, mice were transferred every 24 h at the time of temperature transitions into new experimental cages conditioned with their own smell.
Urine/feces analyses
Mice were acclimated to metabolic cages (Tecniplast 3600 M021). Then urine and feces were collected over three consecutive intervals: 1) 24 h with food ad libitum, 2) first 5 h of fasting, and 3) successive 9 h of fasting (N = 7). The energy content of food and feces was measured with a calorimetric bomb (IKA C200, Staufen, Germany). Metabolizable energy was estimated by subtracting the 24 h hour energy loss in both urine (approximated as the energy lost as glucose, TGs, NEFAs, ketone bodies, proteins and urea), and in feces, to the 24 h feeding gross energy (16.1MJ/kg of chow diet).
Histology and morphometry
After dissection organs were fixed 4 h in 4% PFA -PBS solution at 4°C and were paraffin embedded. Paraffin sections of 4 μm thickness were made and stained with Hematoxylin-Eosin. For cryosections, organs were embedded in OCT (Sakura, Torrance, CA) and frozen on dry-ice.
For β-cell mass quantification, paraffin pancreatic sections were stained with anti-insulin antibody (dil 1:400, AO564, Dako). β-cell mass was calculated by measuring β-cell surface area using ImageJ software in 5-8 sections per pancreas and 4-5 pancreas per group. β-cell mass was extrapolated based on individual pancreas weight.
Protein expression
Proteins were extracted from frozen gastrocnemius using M-PER lysing buffer (78501) with added protease and phosphatase inhibitors (78426, 78429 Thermofisher). Western blot was performed with standard procedures, with the following antibodies (Akt (9272) and Phospho-Akt (9271 Cell Signaling)). Chemiluminescence was detected with SuperSignal West Pico (Pierce). Blots were exposed digitally using the Fusion FX system (Vilber) and bands were quantified using ImageJ.
Real-time quantitative PCR
Total RNA was isolated after homogenisation in TRI-Reagent (Ambion, Thermo Fisher Scientific Inc.) and extraction with RNeasy Mini Kit (Qiagen). Gene expression was analyzed by real-time quantitative PCR (FastStart Universal SYBR Green Master, Roche, USA) in a Stratagene MX3005P Detection System (Agilent Technologies, USA). Ribosomal protein S9 (Rps9) was used as housekeeping gene. Primer sequences are available upon request.
Statistical analyses
Values, expressed as mean ± SEM, were analyzed using Prism 5.0 (GraphPad Software, USA). Student's t-test, one-way or two-way ANOVA with Bonferroni post-test for multiple group comparisons were used to assess statistical significance. For leptin, resistin and insulin levels, data were log-transformed to show normal distribution for statistical analysis. A P value b0.05 was considered statistically significant. ) mice, as previously described [24] and PPARγ expression was undetectable in spleen, liver, muscle, heart, colon, and brain (data not shown). Consistent with the fundamental role of PPARγ in adipogenesis [11, 26] , embryonic fibroblasts isolated from Pparg Δ/Δ embryos could not differentiate in adipocytes (Suppl. Fig. 1 ). Accordingly, Pparg Δ/Δ mice presented a generalized lipoatrophy, characterized by the complete absence of interscapular brown (BAT) and white (WAT) adipose tissues (Fig. 1A) , as well as perirenal (Fig. 1B) , mesenteric, perigonadal and subcutaneous WAT (Fig. 1C) . Circulating adipokines such as resistin and adiponectin were not detectable, while leptin was extremely low in both male and female Pparg Δ/Δ mice ( Fig. 1D and data not shown). While similar at birth, Pparg Δ/Δ mice showed post-natal growth retardation during the suckling period ( Fig. 1E) , during which around 30% of pups died. After weaning (3 weeks), the surviving pups started to grow faster, reaching the same body weight as control mice at 6-7 weeks and becoming heavier than their control littermates between 8 and 12 weeks of age (Fig. 1E) , with no more lethality. Strikingly, the higher body weight in Pparg Δ/Δ mice was almost exclusively due to a very significant increase in lean mass, while fat content was barely augmented with body weight, in contrast to what was observed in littermate control mice (Fig. 1F , G) Indeed, adult Pparg Δ/Δ mice showed organomegaly affecting particularly the liver (Fig. 1C , H) but also intestine and spleen (Suppl. Fig. 2 and [27]), whereas heart and muscle masses were unchanged and reduced, respectively (Suppl. Fig. 2 and [28] ). In absence of adipose tissue, Pparg Δ/Δ mice showed ectopic lipid deposition in the liver (Fig. 1I ), but not in muscle [28] .
Results
Generalized lipodystrophy and organomegalia in Pparg
Deep alterations of glucose homeostasis in Pparg
At 10-12 weeks male and female Pparg Δ/Δ mice revealed a severe increase in plasma glucose, triglycerides (TGs) and free fatty acids (NEFAs) ( Fig. 2A-C) , an impaired glucose tolerance (Fig. 2D) , and insulin resistance as suggested by the poor hypoglycemic response during an Insulin tolerance test (ITT) (Fig. 2E ). Insulin action was also impaired in muscle, as demonstrated by the reduced phosphorylation of AKT upon insulin injection (Suppl. Fig. 3 ). Accordingly, fed Pparg Δ/Δ mice were highly hyperinsulinemic ( Fig. 2F ) with plasma insulin values 16-fold over control values. This hyperinsulinemia was accompanied by a massive enlargement of pancreatic islets ( Fig. 2G ) with a 6.4 fold increase in β-cell mass in Pparg Δ/Δ mice (Fig. 2H ). These data suggest that β-cells are not exhausted by the very high chronic hyperglycemia.
Hyperphagia, hypermetabolism, and metabolic inflexibility in Pparg
In order to get more insight into the metabolic phenotype of Pparg
mice we performed indirect calorimetry experiments. Pparg Δ/Δ mice were hypermetabolic with higher oxygen consumption ( Fig. 3A ) and consequently heat production ( Fig. 3B ), corresponding to a calculated 76% higher daily metabolic rate. Pparg Δ/Δ hypermetabolism was only partially accounted for by the higher lean, metabolically active mass (Fig. 3D ). This hypermetabolism was accompanied by a remarkable hyperphagia ( Fig. 3E) . Interestingly, the circadian oscillations of heat production, food intake, and spontaneous locomotor activity ( Fig. 3C , E, F) were qualitatively maintained, demonstrating a preserved daily rhythmicity, although the amplitude was dampened (night:day activity ratio was 2:1 in Pparg Δ/Δ mice as compared to 3,5:1 in controls; Fig. 3F ).
The preferential use of substrates as energy source was assessed by calculating the respiratory exchange ratio (RER = VCO2/VO2). As expected, control mice presented typical circadian oscillations of the RER (Fig. 3G ), while such rhythmicity was absent in Pparg Δ/Δ mice. Males and females exhibited a similar phenotype. Thus, Pparg Δ/Δ mice are not capable of switching between energy sources depending on the nutritional status, i.e. they are metabolically inflexible. Collectively, these experiments underlined three major metabolic traits in Pparg Δ/Δ mice: hypermetabolism, hyperphagia, and metabolic inflexibility.
Hypermetabolism is not due to an alteration of thermoregulation in
The fact that the lean, metabolically active mass did not fully account for the hypermetabolism of Pparg Δ/Δ mice (see Fig. 3D ) suggested that other parameters might contribute to its onset. Notably, beside their metabolic phenotype, Pparg Δ/Δ present skin alterations, characterized by dryness, lack of the subcutaneous fat layer, short hair and progressive alopecia [24] , which could have an effect on insulation ability. Thus, should thermoregulation be altered in Pparg Δ/Δ mice due to insulation impairment, the difference of metabolic rate between Pparg Δ/Δ and control mice would be expected to disappear in absence of cold stress, i.e. at thermoneutrality. To test this hypothesis, we successively exposed the mice to various ambient temperatures including room temperature (23°C) and thermoneutrality (30°C, 32°C, and 33°C). In both control and Pparg Δ/Δ mice, the metabolic rate decreased from 23°C to 32°C, but remained higher in Pparg Δ/Δ mice than in control mice (Fig. 3H ).
These data suggest that insulation does not play a significant role in the hypermetabolism in Pparg Δ/Δ mice. Interestingly, in both control
and Pparg Δ/Δ mice, a further increase of the ambient temperature from 32°to 33°did not result in further drop, but rather increased the metabolic rate. This suggests that in both genotypes 33°C is beyond the upper limit of the thermoneutral zone, a temperature zone where active cooling is required to prevent hyperthermia with a paradoxical increases of the metabolic rate. Consistent with this notion, rectal temperature in Pparg Δ/Δ mice was slightly low at 23°C, was normal at 30°C but was higher at 32 and 33°C (Fig. 3I) . Control mice on the other hand maintained a constant temperature up to 33°C. Overall, these results indicate that the hypermetabolism in Pparg Δ/Δ mice is not due to an impairement in insulation. 
Fasting intolerance in Pparg
To further explore the metabolic phenotype related to energy homeostasis and metabolic flexibility, we submitted Pparg Δ/Δ mice to overnight (14 h) fasting. Pparg Δ/Δ mice lost more body weight than controls (Fig. 4A) . Although the fat loss was comparable among groups (2 g), fasting led to an almost complete depletion of fat mass in Pparg Δ/Δ mice. In addition, the loss of lean mass in Pparg Δ/Δ mice was twice that in control mice ( Fig. 4B-C) . Fasting resulted in a two-third decrease of glycemia and a striking normalization of hyperinsulinemia in Pparg Δ/Δ mice (Fig. 4D, E) . As expected, blood concentration of both ketone bodies (β-Hydroxybutyric acid (HBA)) and the ketogenic substrates NEFAs was increased upon fasting in control mice. In contrast, in Pparg Δ/Δ mice, NEFA and TG levels were high in the fed state but decreased upon fasting and the fasting- induced increase in ketone bodies was accordingly blunted (Fig. 4F-H) , suggesting that Pparg Δ/Δ mice are unable to normally adjust its metabolism during fasting.
Metabolic inflexibility and fasting-induced torpor in Pparg
To further analyse this phenotype we assessed the metabolic response to a fed, overnight fasted, refed scheme by indirect calorimetry.
In control mice, the RER rapidly dropped close to 0.7 during fasting (shift to lipid metabolism) and reciprocally rebounded close to 1.0 during refeeding (metabolic switch back to carbohydrates). In Pparg Δ/Δ mice, in contrast, the RER remained constant in the 0.8-0.9 range, until 9 h into the fasting (Fig. 5A) . Strikingly, during the second part of the nocturnal fast, the VO 2 and heat production had dramatically dropped about 5-fold (Fig. 5B, C) and locomotor activity was suppressed (Fig. 5D) 
age-matched control littermates (student t-test).
refeeding, Pparg Δ/Δ mice exited torpor and returned to the hypermetabolic state (Fig. 5A-C) . These results further support the notion that Pparg Δ/Δ mice are severely metabolically inflexible and intolerant to fasting.
Urinary energy loss and energy balance in Pparg Δ/Δ mice
Given our previous report of impaired renal function in Pparg Δ/Δ mice [29] , we hypothesized that energy loss in urine may also contribute to energy store depletion and fasting-induced torpor in Pparg Δ/Δ mice.
To estimate energy loss in the feces and urine, we collected them during 24 h in the ad libitum fed state, followed by a second collection during 5 h fasting, and finally a third collection corresponding to the last 9 h of a 14 h fast. This protocol allowed distinguishing the early metabolic responses to fasting, when the metabolic rate was still in the normal range, from the late response, during fasting-induced torpor. Pparg Δ/Δ mice are severely polyuric (Fig. 6A) , consistent with the hyperglycemic and the diabetic state. The water loss is compensated by an important polydipsy (Fig. 6B) . We evaluated the energy lost in urine by measuring the concentration of main metabolites in urine. In the fed state, Pparg Δ/Δ mice lose a very significant amount of glucose (2.6 g/24 h), but also TGs, NEFAs, ketone bodies (HBA) and proteins ( Fig. 6C-G, 24 h fed). In addition, urea excretion was strikingly increased 4.7-fold, suggesting an elevation of aminoacid metabolism (Fig. 6H, 24 h fed) . During fasting, the urinary loss progressively decreased in Pparg Δ/Δ mice for all substrates, including the ketone bodies ( Fig. 6C -G, 5hr and 9 h fasting). This latter result is in stark contrast with control mice in which HBA urinary levels increased over the course of fasting (Fig. 6E) , consistent with the fastinginduced increase in plasma ketone bodies (see also Fig. 4F ).
In line with the polyphagia (Fig. 6I) , during the normal feeding day, we also observed a 3-fold increase of the amount of feces produced by Pparg Δ/Δ mice (Fig. 6J) , which resulted in a 3-fold higher energy loss compared to control mice (Fig. 6K) , since feces density was not altered (Fig. 6L) .
By recapitulating the various energy losses, one can calculate the portion of food energy available for body metabolism, i.e. the metabolizable energy (Fig. 6M ). The energy loss in the feces produced by Pparg Δ/Δ mice accounted for ca. 25% of energy intake, similar to controls. In fact, the observed lower proportion of metabolizable energy in Pparg Δ/Δ mice (45% vs 75% in controls; Fig. 6M ) was rather due to the very significant (30%) energy loss in urine, which thus likely contributes to inducing hyperphagia in Pparg Δ/Δ mice.
Finally, taking into account the higher energy intake due to hyperphagia, the daily metabolizable energy was 79% higher in Pparg Δ/Δ mice compared to controls (15.2 vs 8.4 kcal/day), in direct proportion to their 76% higher daily metabolic requirements (Fig. 3B) .
Overall these data indicate that hyperphagia as well as intolerance to fasting in Pparg Δ/Δ mice result from excess energy requirements related to both urinary energy loss and hypermetabolism. 
Lipid and protein metabolism alterations upon fasting in Pparg Δ/Δ mice
To get further insight into the impaired response to fasting, we analyzed the gene expression of key regulators in the three main pathways activated in the liver upon fasting, i.e. glycogenolysis, gluconeogenesis, and lipid oxidation. In the fed state, mRNA levels of Pdk4, a key regulator of gluconeogenesis, were normal in Pparg Δ/Δ mice. However, whereas Pdk4 expression was strongly increased only after an overnight fast in controls, it was increased to similar levels already after a 5 h fast in Pparg Δ/Δ mice, consistent with an earlier requirement for gluconeogenesis in Pparg Δ/Δ mice (Fig. 7A) . Along the same line, Pgc1a, another important regulator of gluconeogenesis which induces the expression of Pck1, was remarkably elevated to overnight fasted levels already in the fed and 6 h fasted states (Fig. 7B, C) . Overall, these results are consistent with both the early fasting stress and the diabetic state of Pparg Δ/Δ mice.
PPARα, a key regulator of numerous genes involved in fatty acid oxidation upon activation by fasting, was expressed at similar levels in fed control and Pparg Δ/Δ mice and increased similarly after 5 h of fasting.
After an overnight fast, however, PPARα expression was strikingly suppressed (Fig. 7D) , along with the peroxisomal β-oxidation gene Acetyl- CoA Acytransferase 1 (Acaa1), and the PPARα target, ketogenic gene Hmgcs2 (Fig. 7E-F) , whereas no changes were found for the hepatic carnitine palmitoyltransferase (Cpt1a; Fig. 7G ). Collectively, these data are in line with the accelerated catabolic state and early substrate depletion during fasting in Pparg Δ/Δ mice.
Given the substantial loss of lean mass upon fasting and the high urea excretion in Pparg Δ/Δ mice, we also explored the metabolism of aminoacids. As an index of aminoacid metabolism, we analyzed the expression of genes of the urea cycle, which detoxifies the ammonia produced by aminoacid degradation. Strikingly, four out of five genes involved in the urea cycle are significantly increased in Pparg Δ/Δ mice (Got1, Asl, Ass1, Cps1, but not Oct1; Fig. 7H-L) , both in the fed and in the fasting states, suggesting that facing the metabolic inflexibility, Pparg Δ/Δ mice developed an adaptive glutamine utilization. Thus, the spectacular increase in lean mass in Pparg Δ/Δ mice may be part of an adaptive mechanism to ensure energy homeostasis.
Discussion
In the present report, we provide a thorough exploration of the metabolic status of mice totally deprived of adipose tissue, through constitutive systemic deletion of Pparg.
Consistent with the key role of PPARγ in adipose tissue formation, Pparg Δ/Δ mice are totally lipodystrophic, with no structured or unstructured fat depots, except in the liver where steatosis is present. In contrast, these mice display an important increase in lean mass, accompanied by organomegalia. As a consequence of the lipoatrophy, Pparg Δ/Δ develop severe type-2 diabetes, characterized by hyperglycemia, hyperinsulinemia, polyphagia, polydispsia and polyuria. In depth metabolic analyses reveal four major findings: first, a remarkable metabolic inflexibility in both ad libitum fed state and fed/fasted/refed transitions, with severe intolerance to fasting; second, a massive urinary loss of energy in form of glucose, lipids and proteins; third, a hypermetabolic phenotype related to the increase in lean mass but not to insulation defects, which, together with urinary energy loss, contributes to the major hyperphagia of Pparg Δ/Δ mice; fourth, an activation of the urea cycle, suggesting an adaptive mechanism to ensure energy homeostasis in absence of adipose tissue. The exploration of the effects of systemic ablation of PPARγ is an important step towards understanding how distinct PPARγ activities are integrated in the whole organism, which might be relevant in a clinical perspective considering that PPARγ agonists (TZDs) were the treatment of choice for type-2 diabetes before their use was restricted due to serious side effects. Here we provide the first study of the effects of a full, systemic ablation of PPARγ. Interestingly, the metabolic phenotype carried by Pparg+/− and Pparg Δ/Δ mice is quite different, with Pparg+/− being protected against insulin-resistance, rather than being more prone to develop this metabolic disorder, as it is seen in Pparg Δ/Δ [30, 31] . The lack of the Pparg gene dosage effect on the metabolic phenotype is likely due to the total absence of adipose tissue in Pparg
compared to a diminished propensity to increase upon high fat diet in Pparg+/−. The total lack of adipose tissue in the former is bringing its load of metabolic consequences, which make Pparg Δ/Δ mice a more powerful model to understand fundamental aspects of energy homeostasis in lipoatrophy rather than to disentangle cell-autonomous effects of PPARγ.
To the best of our knowledge, Pparg Δ/Δ mice are the first available model fully deprived of WAT and BAT throughout life. A-ZIP/F-1 mice, one of the first models resembling the Berardinelli-Seip syndrome of generalized lypodystrophy, had a WAT reduction of almost 99% but presented a normal BAT at birth that shrank with age [32] . Mice lacking seipin (Bscl2), the gene whose mutation is one of the causes of the Berardinelli-Seip syndrome, have residual fat pads in visceral and subcutaneous locations, before the age of 6 months [33] [34] [35] . Recently, another model of severe lipoatrophy was obtained through Adipoq-Cre mediated PPARγ deletion (PPARγFKO). However, while 8 days old PPARγFKO mice had virtually no BAT, some inguinal and interscapular mature adipocytes were still detectable [17] . Therefore, Pparg Δ/Δ mice represent a unique model to study the systemic and local effects of total lack of fat tissue [24] . Several observations done in Pparg Δ/Δ mice also illustrate some limitations of the interpretation of results obtained via tissue-or cellspecific PPARγ gene deletion. As an example, PPARγ mutant mice presented hepatomegaly and steatosis, which, at first sight, could seem unexpected, especially considering that PPARγ is commonly upregulated in the steatotic liver. Furthermore, specific liver PPARγ deletion was shown to ameliorate hepatosteatosis in both A-ZIP/F-1 and diet-induced obese mice [36, 37] , while TZD treatment reduced plasma glucose and triglycerides in liver-specific and muscle-specific PPARγ-deleted mice [36] . However, the phenotype observed in Pparg Δ/Δ mice demonstrates that, in the context of full deprivation of fat, PPARγ is not required for lipid droplet formation in hepatocytes.
A second interesting aspect of Pparg Δ/Δ mice was enhanced beta cell mass and insulin production in face of hyperglycemia. However the relative contribution of PPARγ deletion in the context of the diabetic compensation remains unclear. Rosen et al. showed that loss of PPARγ in pancreatic β-cells was associated with a hyperplastic response, but no metabolic abnormalities [38] . More recently, a FoxO1/PPARγ mediated network was proposed as a core element for β-cell compensation and failure in response to metabolic stress [39] . Overall our study shows that lack of PPARγ does not lead to defects in pancreatic beta cell function. Lipodystrophic Pparg Δ/Δ mice showed a spectacular increase in the lean mass. This phenotype is likely related to lipodystrophy rather than to PPARγ deletion, as it was also reported in A-ZIP/F-1 mice [32] . The causal relationship between lipodystrophy and increased lean mass is however unknown. Upon fasting aminoacids, mainly coming from catabolic wasting of lean mass, are used for gluconeogenesis. In Pparg Δ/Δ mice, the expression of genes of the urea cycle was considerably increased in both ad libitum fed and fasted states. Accordingly, Pparg Δ/Δ mice display a rise in the 24 h urea excretion in the fed state. This suggests an increase in aminoacid metabolism, likely related to hyperphagia-associated higher protein intake and possibly also to a higher mobilization of endogenous proteins for metabolism in the post-absorptive state. During fasting, however, there was no more elevation of urea excretion, despite the higher expression of urea cycle genes, possibly due to an exhaustion of the substrates easily available. In this context, the fact that Pparg Δ/Δ mice lose twice as much lean mass as controls during fasting may be due in part to the higher urinary protein loss. Overall it is tempting to speculate that the increased lean mass in Pparg Δ/Δ mice is a metabolic adaptation to lipodystrophy and its complications. Pparg Δ/Δ mice display an intriguing hypermetabolism that seems to be mainly but not entirely explained by the increase in lean, metabolically active mass. At first sight, this might suggest that other (e.g. cell-autonomous) mechanisms might account for part of the hypermetabolism. However, it may more likely reflect a limitation of normalization to lean mass -which relies on the assumption that the mass-specific metabolic rate remains constant when lean mass changes. Indeed, this assumption is not true in Pparg Δ/Δ mice that show a disproportionately high enlargement of the liver compared to the total increase in lean mass. Moreover, liver has, together with the muscle, the highest mass-specific metabolic rate [40] and is the organ which correlates best to basal metabolic rate [41] . Thus the hypermetabolism in Pparg Δ/Δ mice is in many respects unlike other hypermetabolic clinical situations such as HIV-associated lipodystrophy [42] , burn injury or cancer, which are associated with sarcopenia or cachexia, particularly in chronic situations. Metabolic inflexibility in Pparg Δ/Δ mice -as operationally defined by decreased variations in the respiratory quotient during nutritional changes, independently of the underlying mechanisms -is suggested by the disappearance of physiological oscillations of RER in the ad libitum state, as well as by the absence of RER drop to 0.7 during transitions from ad libitum to fasted and rebound. Although the urinary loss of glucose (and to a lesser extent of ketone bodies) in Pparg Δ/Δ mice may artificially lower the RER in the fed state, thereby flattening its circadian pattern, this would not explain why upon fasting the RER does not rapidly drop down to expected fasted values. The lack of organized fat tissue under hormonal control of lipolysis by insulin and catecholamines is one possible explanation for this metabolic inflexibility, unlike in type 2 diabetic patients where metabolic inflexibility rather reflects an impaired insulin axis [43] [44] [45] . Upon fasting, Pparg Δ/Δ mice rapidly deplete their body energy stores and enter torpor, a hypometabolic, hibernation-like state. Although lipodystrophy per se plays a major role, it is interesting to note that leptin deficiency has been described as a possible actor for the entry in torpor-like state upon fasting, as observed in both obese ob/ob mice and lipodystrophic A-ZIP/F-1 mice [46] . Several intriguing questions remain, such as how is feeding regulated in Pparg Δ/Δ mice in absence of leptin, and to what extent is the absence of leptin relevant to the increase in body weight and lean mass compared to controls beyond 8 weeks of age. More generally, this discussion highlights the complexity of the metabolic interplay between lack of adipose tissue, increased lean mass, hypermetabolism, hyperphagia and metabolic inflexibility. A molecular and system approach to understand the possible mechanisms of adaptation would provide some clues on fundamental aspects of energy metabolism, as well as on related questions of clinical relevance.
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